A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia
PHASE4CompletedINTERVENTIONAL
Enrollment
66
Participants
Timeline
Start Date
November 30, 2003
Study Completion Date
July 31, 2006
Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG
Atomoxetine (Strattera)
Trial Locations (1)
15213
Western Psychiatric Institute and Clinic, Pittsburgh
All Listed Sponsors
collaborator
Stanley Medical Research Institute
OTHER
lead
University of Pittsburgh
OTHER
NCT00222794 - A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter